Hygrine

Hygrine at a Glance

Hygrine is a small pyrrolidine alkaloid found as a minor constituent of coca (Erythroxylum coca and E. novogranatense) and of several other tropane-producing plants. Chemically it is 1-(1-methylpyrrolidin-2-yl)propan-2-one — a methylated pyrrolidine ring bearing an acetonyl side chain ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}.

The honest headline for this molecule is that its importance is biosynthetic and chemotaxonomic, not pharmacological. Hygrine is one of roughly eighteen alkaloids identified across cultivated coca varieties, and it sits far below cocaine in abundance ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}. It has no meaningful standalone pharmacology in people or animals; where it matters, it matters as a marker of the tropane-alkaloid pathway and as a chemical fingerprint used to tell Erythroxylum material apart ^{1,5Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →}.

This page treats hygrine as what it is: a pathway molecule and a chemotaxonomic signpost, not a drug or a supplement ingredient.

A Pyrrolidine Precursor in the Tropane-Alkaloid Pathway

This is the point of the page. Hygrine is a pyrrolidine alkaloid tied to the branch of metabolism that builds the tropane alkaloids — the family that leads, in Erythroxylum, to tropinone, tropine and the coca alkaloids ^{2,4Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 4Dräger B · 2006Tropinone reductases, enzymes at the branch point of tropane alkaloid metabolismView study →}.

The shared starting point is the N-methyl-Δ¹-pyrrolinium cation, a reactive five-membered iminium intermediate. Condensation of that cation with an acetate/malonate-derived unit gives a β-keto side chain; the same chemistry is what ultimately closes into the bicyclic tropinone ring on the way to tropine and, downstream, the coca alkaloids ^{2,3Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 3Nguyen TK et al. · 2015Unravelling the architecture and dynamics of tropane alkaloid biosynthesis pathways using metabolite correlation networksView study →}. Hygrine is the open-chain (still monocyclic) pyrrolidine that arises from this branch, and dimerisation of the same building blocks yields its paired relative cuscohygrine ^{2,6Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}.

An important nuance kept honest here: hygrine has long been described as an intermediate on the way to tropinone, but modern pathway work treats the N-methylpyrrolinium cation as the true pivot and leaves open whether hygrine is an obligate on-pathway intermediate or a shunt/side product of that branch ^{2,3Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 3Nguyen TK et al. · 2015Unravelling the architecture and dynamics of tropane alkaloid biosynthesis pathways using metabolite correlation networksView study →}. Either way, its diagnostic value is real — hygrine and cuscohygrine mark tissue that is running the pyrrolidine/tropane machinery ^{2,5Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →}.

• Upstream: ornithine/putrescine → N-methylputrescine → N-methyl-Δ¹-pyrrolinium cation (the branch point) ^{2,4Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 4Dräger B · 2006Tropinone reductases, enzymes at the branch point of tropane alkaloid metabolismView study →}.
• Hygrine: the monocyclic pyrrolidine formed from that branch; cuscohygrine is the dimeric partner ^{2,6Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}.
• Downstream (tropane arm): the same cation feeds ring closure to tropinone → tropine (tropinone reduced by tropinone reductase), then esterification toward the coca alkaloids such as cocaine ^{2,4,8Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 4Dräger B · 2006Tropinone reductases, enzymes at the branch point of tropane alkaloid metabolismView study →Reference 8Hu X et al. · 2023ReviewTropinone reductase: a comprehensive review on its role as the key enzyme in tropane alkaloids biosynthesisView study →}.

What It's Used For

There is very little “pharmacology of hygrine” to report, because the molecule’s significance is chemical, not therapeutic. The literature that exists is about how hygrine is made and how it is used to identify plant material — not about effects of the isolated alkaloid in animals or people.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type and volume. A beta, not a validated metric. Note the unusual profile: the best-evidenced “applications” here are a biochemical role and an analytical one, not a health effect, and the intrinsic-activity row is deliberately near-zero.

01Biosynthetic Precursor / Pathway MoleculePromising48%The N-methylpyrrolinium branch that feeds tropinone → tropine → coca alkaloids; hygrine as intermediate/shunt ^{2,3,4Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 3Nguyen TK et al. · 2015Unravelling the architecture and dynamics of tropane alkaloid biosynthesis pathways using metabolite correlation networksView study →Reference 4Dräger B · 2006Tropinone reductases, enzymes at the branch point of tropane alkaloid metabolismView study →}

02Chemotaxonomic Marker of ErythroxylumShaky30%One of ~18 identified coca alkaloids; used to profile leaf/seed and distinguish cultigens ^{1,5,6Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}

03Intrinsic Pharmacological ActivityShaky8%No isolate clinical or meaningful preclinical dataset; the coca activity belongs to cocaine ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}

Mechanisms

The load-bearing point is the last row: hygrine sits on the pathway that makes the active coca alkaloids, but it is not one of them and has no defined pharmacological target of its own ^{1,2Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →}.

Pharmacokinetics

There is no dedicated pharmacokinetic dataset for hygrine — it is not administered as a drug and has not been characterised for absorption, distribution, metabolism or half-life in humans or animals. It is a small, basic pyrrolidine alkaloid present in coca and related plants at trace-to-minor levels ^{1,6Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}. Any pharmacokinetics that matter for coca as a plant are those of cocaine, covered on its own page.

Clinical Trials

There are no clinical trials of hygrine as an isolate — it is a biosynthetic-pathway molecule and chemotaxonomic marker, not a candidate drug. What exists for hygrine is plant-biochemistry and analytical chemistry (pathway characterisation, alkaloid profiling), not human research ^{1,2,3,5Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 3Nguyen TK et al. · 2015Unravelling the architecture and dynamics of tropane alkaloid biosynthesis pathways using metabolite correlation networksView study →Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →}.

Last checked: July 2026.

Isolate vs. Plant Studies

The isolate-vs-plant axis here is unusual: the isolate evidence is biochemical and analytical, not therapeutic. Where hygrine appears as a defined species it is as a pathway intermediate in tropane-alkaloid biosynthesis studies or as a peak in an alkaloid profile used to characterise Erythroxylum material ^{2,3,5,6Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 3Nguyen TK et al. · 2015Unravelling the architecture and dynamics of tropane alkaloid biosynthesis pathways using metabolite correlation networksView study →Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}. In the plant setting it is only ever a minor/trace alkaloid in a much larger mixture dominated by cocaine, and it is not isolated as a driver of any effect ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}. So there is no whole-plant or human study that turns on hygrine, and any activity associated with coca belongs to other molecules.

Its Role in Plants

In coca and other tropane-producing plants, hygrine is best understood as a pyrrolidine metabolite on the alkaloid-building branch rather than a defensive end-product in its own right. It is generated from the N-methylpyrrolinium cation that the plant also commits to tropinone and the tropane alkaloids, and it co-occurs with its dimeric relative cuscohygrine ^{2,4Reference 2Kohnen-Johannsen KL · 2019Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ProductionView study →Reference 4Dräger B · 2006Tropinone reductases, enzymes at the branch point of tropane alkaloid metabolismView study →}.

Because hygrine and cuscohygrine track the operation of this pathway, their presence and pattern are informative about a plant’s alkaloid chemistry — one reason they feature in chemotaxonomic treatments of tropane-alkaloid distribution across genera and families ^{5Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →}. The defensive, biologically active end-products of the pathway in coca are the ester tropanes (chiefly cocaine), not the pyrrolidine precursors ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}.

Prevalence in Nature

Hygrine occurs as a minor alkaloid of coca — reported across Erythroxylum coca and E. novogranatense as one of roughly eighteen alkaloids identified in cultivated material, and detected in coca seed as well as leaf ^{1,6Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}. It is consistently a low-abundance constituent, far below cocaine, and analysts typically report it as one peak in an alkaloid profile rather than quantifying it precisely ^{1,6Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}.

Beyond Erythroxylum, hygrine and related pyrrolidine alkaloids are reported among the tropane-alkaloid chemistry of other plant families that run the same pathway (various Solanaceae and Convolvulaceae), which is why they appear in broad chemotaxonomic surveys of tropane-alkaloid distribution ^{5Reference 5Griffin WJ · 2000Chemotaxonomy and geographical distribution of tropane alkaloidsView study →}. Quantitative figures are rarely given, so the honest statement is that hygrine is present at trace-to-minor levels without a well-documented percentage.

Discovery & Synthesis

Hygrine entered chemistry through the nineteenth-century investigation of coca, in which chemists resolving the coca-leaf alkaloids described a series of minor bases alongside cocaine; hygrine is commonly attributed to Carl Liebermann (1889), of the same era that characterised its dimeric partner cuscohygrine. It has never been the subject of a celebrated total-synthesis campaign the way tropinone was — its interest has stayed biosynthetic and analytical rather than synthetic.

Today hygrine is not manufactured as a product. It is encountered as a naturally occurring minor alkaloid in coca and related plants and as a reference marker in analytical alkaloid profiling, not as an extracted or synthesised commercial compound ^{1,6Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →Reference 6Casale JF et al. · 2005Alkaloid content of the seeds from Erythroxylum coca var. cocaView study →}.

Patents: not yet researched.

Toxicity & Safety

Hygrine carries a low flag. It is a minor pyrrolidine alkaloid with no characterised pharmacological target and no isolate toxicity dataset of its own; the stimulant and toxic effects associated with coca belong to cocaine, not to the pyrrolidine precursors ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}. “Low” here reflects the absence of demonstrated activity for the isolated molecule — it should not be read as “safe to consume.” Hygrine is not a food, supplement or medicine, it is a trace intermediate, and it has essentially no safety characterisation as an isolate.

Safety at a Glance

✅ Low / no toxicity

• Not the active coca alkaloid. Hygrine is a minor pyrrolidine precursor with no characterised receptor/transporter target; the stimulant and local-anaesthetic activity of coca is cocaine’s, not hygrine’s ^{1Reference 1Novák M et al. · 1984Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatenseView study →}.
• Do not read this as coca being benign. Coca’s controlled-substance alkaloid, cocaine, is a serious drug — hygrine’s inertness says nothing about the plant’s overall risk.
• No isolate safety data. Hygrine is a trace biosynthetic intermediate, not a characterised ingredient; absence of toxicity reports is not evidence of safety.
• Don’t infer herb safety from it. Whether coca or any tropane plant is safe is decided on the herb page, where the whole alkaloid mixture and legal status are considered — not from the inertness of one precursor molecule.

Dosage

There is no dose for hygrine. It is not used therapeutically, has no established human dosing, and is present in plants only as a trace/minor alkaloid. The coca alkaloid with real pharmacology, cocaine, is a controlled substance and not a self-dosed agent; hygrine itself is simply a pathway molecule. Any number you might see attached to “hygrine” is an analytical measurement of plant content, not a recommendation.

References

1. Novák M, Salemink CA, Khan I (1984). Biological activity of the alkaloids of Erythroxylum coca and Erythroxylum novogranatense. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/6379304/
2. Kohnen-Johannsen KL, Kayser O (2019). Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and Production. Molecules. https://pubmed.ncbi.nlm.nih.gov/30813289/
3. Nguyen TK, Jamali A, Lanoue A, Gontier E (2015). Unravelling the architecture and dynamics of tropane alkaloid biosynthesis pathways using metabolite correlation networks. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/25823585/
4. Dräger B (2006). Tropinone reductases, enzymes at the branch point of tropane alkaloid metabolism. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/16426652/
5. Griffin WJ, Lin GD (2000). Chemotaxonomy and geographical distribution of tropane alkaloids. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/10746874/
6. Casale JF, Toske SG, Colley VL (2005). Alkaloid content of the seeds from Erythroxylum coca var. coca. Journal of Forensic Sciences. https://pubmed.ncbi.nlm.nih.gov/16382835/
7. Casale JF, Mallette JR, Jones LM (2014). Chemosystematic identification of fifteen new cocaine-bearing Erythroxylum cultigens grown in Colombia for illicit cocaine production. Forensic Science International. https://pubmed.ncbi.nlm.nih.gov/24561557/
8. Hu X, Liu W, Yan Y, Deng H, Cai Y (2023). Tropinone reductase: a comprehensive review on its role as the key enzyme in tropane alkaloids biosynthesis. International Journal of Biological Macromolecules. https://pubmed.ncbi.nlm.nih.gov/37839598/

View all 8 references▾